Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot

Cancer Biology and Therapy

Volumn 3, Issue 6, 2004, Pages 534-537

  Van Der Heijden, Michiel S ^a   Brody, Jonathan R ^a   Kern, Scott E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer; FANCD2; FANCF; Fanconi Anemia; Mitomycin C

Indexed keywords

MITOMYCIN; FANCD2 PROTEIN, HUMAN; FANCONI ANEMIA GROUP D2 PROTEIN; NUCLEAR PROTEIN; UBIQUITIN;

ARTICLE; ASTROCYTOMA; BILE DUCT CANCER; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; FANCONI ANEMIA; GENETIC SCREENING; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CARCINOMA; MALE; PROSTATE CANCER; UBIQUITINATION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOBLOTTING; MALE; MITOMYCIN; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UBIQUITIN;

EID: 21644441072     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.6.844     Document Type: Article

References (20)

1. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249-56.
2. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003; 3:23-34.
3. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2:446-57.
4. Hewlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297:606-9.
5. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003; 63:2585-8.
6. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003; 9:568-74.
7. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003; 72:1-12.
8. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999; 91:1310-6.
9. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003; 129:106-12.
10. Brody JRKS. Sodium boric acid: A Tris-free, cooler conductive medium for DNA electrophoresis. Biotechniques 2004; 36:214-216.
11. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 1996; 93:11400-6.
12. Naf D, Kupfer GM, Suliman A, Lambert K, D'Andrea AD. Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol Cell Biol 1998; 18:5952-60.
13. Garcia-Higuera I, Kuang Y, Naf D, Wasik J, D'Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19:4866-73.
14. Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Exp Hematol 2001; 29:1448-55.
15. Kuang Y, Garcia-Higuera I, Moran A, Mondoux M, Digweed M, D'Andrea AD. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity. Blood 2000; 96:1625-32.
16. D'Andrea AD. The Fanconi road to cancer. Genes Dev 2003; 31:31.
17. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35:165-70.
18. Gregory RC, Taniguchi T, D'Andrea AD. Regulation of the Fanconi anemia pathway by monoubiquitination. Semin Cancer Biol 2003; 13:77-82.
19. Rogers CD, Van Der Heijden MS, Brune K, Yeo CJ, Hruban RH, Kern SE, et al. The genetics of FANCC and FANCG in familial pancreatic cancer. Cancer Biol Ther 2004; In press.
20. Seal S, Barfoot R, Jayatilake H, Smith P, Renwick A, Bascombe L, et al. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res 2003; 63:8596-9.